tiprankstipranks
Dr. Hoenle AG (GB:0O27)
LSE:0O27

Dr. Hoenle AG (0O27) Income Statement

0 Followers

Dr. Hoenle AG Income Statement

Last quarter (Q1 2023), Dr. Hoenle AG's total revenue was €27.62M, a decrease of -17.36% from the same quarter last year. In Q1, Dr. Hoenle AG's net income was €1.92M. See Dr. Hoenle AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
€ 120.73M€ 126.53M€ 115.17M€ 93.88M€ 107.75M€ 126.49M
Cost of Revenue
€ 60.93M€ 64.24M€ 45.83M€ 33.34M€ 34.92M€ 41.09M
Gross Profit
€ 59.80M€ 62.29M€ 69.34M€ 60.54M€ 72.82M€ 85.40M
Operating Expense
€ 74.09M€ 74.36M€ 69.13M€ 51.81M€ 55.88M€ 55.02M
Operating Income
€ -14.29M€ -12.08M€ 216.00K€ 8.72M€ 16.95M€ 30.38M
Net Non Operating Interest Income Expense
€ -1.48M€ -1.46M€ -1.03M€ -303.00K€ -149.00K€ -296.00K
Other Income Expense
------
Pretax Income
€ -13.71M€ -11.55M€ -608.00K€ 7.85M€ 16.87M€ 30.40M
Tax Provision
€ 1.09M€ 1.65M€ 4.25M€ 2.24M€ 4.48M€ 8.67M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ -14.64M€ -13.36M€ -4.82M€ 5.68M€ 12.48M€ 21.74M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-€ 2.11M€ 2.09M€ 1.46M€ 4.00M€ 4.45M
Total Expenses
€ 135.01M€ 138.61M€ 114.95M€ 85.15M€ 90.80M€ 96.11M
Net Income From Continuing And Discontinued Operation
€ -14.64M€ -13.36M€ -4.82M€ 5.68M€ 12.48M€ 21.74M
Normalized Income
€ -15.95M€ -14.34M€ -4.93M€ 5.81M€ 12.47M€ 21.67M
Interest Expense
€ 1.59M€ 1.53M€ 1.17M€ 496.00K€ 162.00K€ 318.00K
EBIT
€ -12.12M€ -10.02M€ 562.00K€ 8.34M€ 17.03M€ 30.71M
EBITDA
€ 2.01M€ 4.46M€ 14.07M€ 14.95M€ 20.35M€ 33.87M
Currency in EUR

Dr. Hoenle AG Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis